Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-16

Clinical Trial Update: Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of asenapine using an active control in adults with schizophrenia or schizoaffective disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED